Tendencias Ahora
Listas Principales
Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.
¿Ya eres miembro? Iniciar sesión
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and ... Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. Mostrar más
Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 7.539 | 7.539 | 7.539 | 0 | 0 | CS |
4 | 0 | 0 | 7.539 | 7.539 | 7.539 | 0 | 0 | CS |
12 | 0 | 0 | 7.539 | 7.539 | 7.539 | 0 | 0 | CS |
26 | -1.386 | -15.5294117647 | 8.925 | 9.1875 | 5.4355 | 1430391 | 6.95413076 | CS |
52 | 3.094 | 69.6062992126 | 4.445 | 14.595 | 2.835 | 7228061 | 6.26505053 | CS |
156 | -675.311 | -98.8959507945 | 682.85 | 1470 | 2.835 | 3624977 | 83.85023089 | CS |
260 | -2109.961 | -99.6439669421 | 2117.5 | 5862.5 | 2.835 | 2766175 | 367.74873044 | CS |
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones